Your browser doesn't support javascript.
loading
High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients.
Oliva-Ariza, Guillermo; Fuentes-Herrero, Blanca; Carbonell, Cristina; Lecrevisse, Quentin; Pérez-Pons, Alba; Torres-Valle, Alba; Pozo, Julio; Martín-Oterino, José Ángel; González-López, Óscar; López-Bernús, Amparo; Bernal-Ribes, Marta; Belhassen-García, Moncef; Pérez-Escurza, Oihane; Pérez-Andrés, Martín; Vazquez, Lourdes; Hernández-Pérez, Guillermo; García Palomo, Francisco Javier; Leoz, Pilar; Costa-Alba, Pilar; Pérez-Losada, Elena; Yeguas, Ana; Santos Sánchez, Miryam; García-Blázquez, Marta; Morán-Plata, Francisco Javier; Damasceno, Daniela; Botafogo, Vitor; Muñoz-García, Noemí; Fluxa, Rafael; Contreras-Sanfeliciano, Teresa; Almeida, Julia; Marcos, Miguel; Orfao, Alberto.
Afiliação
  • Oliva-Ariza G; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Fuentes-Herrero B; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Carbonell C; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Lecrevisse Q; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Pérez-Pons A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Torres-Valle A; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Pozo J; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Martín-Oterino JÁ; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • González-López Ó; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.
  • López-Bernús A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Bernal-Ribes M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Belhassen-García M; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Pérez-Escurza O; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain.
  • Pérez-Andrés M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Vazquez L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Hernández-Pérez G; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • García Palomo FJ; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Leoz P; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Costa-Alba P; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Pérez-Losada E; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Yeguas A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Santos Sánchez M; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • García-Blázquez M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Morán-Plata FJ; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Damasceno D; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.
  • Botafogo V; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca (Universidad de Salamanca), Salamanca, Spain; Cytometry Service (NUCLE
  • Muñoz-García N; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Fluxa R; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Contreras-Sanfeliciano T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Almeida J; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.
  • Marcos M; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.
  • Orfao A; Department of Infectious Diseases, University Hospital of Salamanca, Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain.
Blood ; 141(3): 309-314, 2023 01 19.
Article em En | MEDLINE | ID: mdl-36399707
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Neoplasias de Plasmócitos / COVID-19 / Linfocitose Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Neoplasias de Plasmócitos / COVID-19 / Linfocitose Idioma: En Ano de publicação: 2023 Tipo de documento: Article